e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

                           

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 30, 2003

ATRIX LABORATORIES, INC.

(Exact Name of Registrant as Specified in Charter)
         
Delaware   0-18231   84-1043826
 
 
(State or Other   (Commission File Number)   (IRS Employer
Jurisdiction of     Identification No.)
Incorporation)        
     
2579 Midpoint Drive, Fort Collins, Colorado   80525
 
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code (970) 482-5868

 

TABLE OF CONTENTS

Item 12. Results of Operations and Financial Condition.
SIGNATURES
EXHIBIT INDEX
EX-99.1 Press Release

Table of Contents

Item 12.  Results of Operations and Financial Condition.

          On October 30, 2003, Atrix Laboratories, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2003. A copy of the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.

2

Table of Contents

SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

       
    ATRIX LABORATORIES, INC.
       
    By:  /s/ Mark A. Wallace
     
      Mark A. Wallace
      Chief Financial Officer, Secretary
      and Treasurer
Date: October 30, 2003      

3

Table of Contents

EXHIBIT INDEX

     
Exhibit   Description
 
99.1   Press Release dated October 30, 2003